LAND, K.M., M.G. DELLGADILLO-CORREA, Jan TACHEZY, Štěpánka VAŇÁČOVÁ, C.L. HSIEH, R. SUTAK and Patricia J. JOHNSON. Targeted gene replacement of a ferredoxin gene in Trichomonas vaginalis does not lead to metronidazole resistance. Molecular Microbiology. 2004, vol. 51, No 1, p. 115-122. ISSN 0950-382X.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Targeted gene replacement of a ferredoxin gene in Trichomonas vaginalis does not lead to metronidazole resistance
Name in Czech Targeted gene replacement of a ferredoxin gene in Trichomonas vaginalis does not lead to metronidazole resistance
Authors LAND, K.M. (840 United States of America), M.G. DELLGADILLO-CORREA (840 United States of America), Jan TACHEZY (203 Czech Republic), Štěpánka VAŇÁČOVÁ (203 Czech Republic, guarantor), C.L. HSIEH (840 United States of America), R. SUTAK (703 Slovakia) and Patricia J. JOHNSON (840 United States of America).
Edition Molecular Microbiology, 2004, 0950-382X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10600 1.6 Biological sciences
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 5.959
RIV identification code RIV/00216224:14310/04:00036237
Organization unit Faculty of Science
UT WoS 000186974100011
Keywords (in Czech) Trichomonads; ferredoxin; metronidazole; drug resistance; gene knock-out
Keywords in English Trichomonads; ferredoxin; metronidazole; drug resistance; gene knock-out
Tags drug resistance, ferredoxin, gene knock-out, metronidazole, Trichomonads
Tags International impact, Reviewed
Changed by Changed by: prof. Mgr. Štěpánka Vaňáčová, Ph.D., učo 105562. Changed: 29/3/2010 16:09.
Abstract
Ferredoxin, Fd, is often deficient in metronidazole-resistant strains of Trichomonas vaginalis and is thought to be necessary for drug activation. To directly test whether Fd is essential for metronidazole susceptibility, gene replacement technology has been developed for T. vaginalis. The selectable marker gene neomycin phosphotransferase (NEO) flanked by approximately 2.6 and approximately 2.0 kBp of the Fd 5' and 3' flanking regions (pKO-FD-NEO) was introduced into cells on linear DNA and selected for NEO gene expression. Stable transformants were shown to contain the NEO gene in the Fd locus and to have completely lost the Fd gene. Northern and immunoblot analyses confirm the loss of Fd mRNA and protein in pKO-FD-NEO cells. Analyses of the activity of hydrogenosomal proteins in Fd KO cells show a fourfold increase in hydrogenase activity and a 95% decrease in pyruvate/ferredoxin oxidoreductase (PFO) activity. In contrast, PFO and hydrogenase mRNA levels are unchanged. Surprisingly, Fd KO cells are not resistant to metronidazole under aerobic or anaerobic conditions. These cells are capable of producing molecular hydrogen, albeit at 50% the level of the parental strain, demonstrating that the Fd gene product eliminated in KO cells is neither necessary for hydrogen production nor metronidazole activation. Together these data indicate the presence of unidentified Fds or flavodoxins capable of drug activation or an unidentified mechanism that does not require either PFO or Fd for metronidazole activation.
Abstract (in Czech)
Ferredoxin, Fd, is often deficient in metronidazole-resistant strains of Trichomonas vaginalis and is thought to be necessary for drug activation. To directly test whether Fd is essential for metronidazole susceptibility, gene replacement technology has been developed for T. vaginalis. The selectable marker gene neomycin phosphotransferase (NEO) flanked by approximately 2.6 and approximately 2.0 kBp of the Fd 5' and 3' flanking regions (pKO-FD-NEO) was introduced into cells on linear DNA and selected for NEO gene expression. Stable transformants were shown to contain the NEO gene in the Fd locus and to have completely lost the Fd gene. Northern and immunoblot analyses confirm the loss of Fd mRNA and protein in pKO-FD-NEO cells. Analyses of the activity of hydrogenosomal proteins in Fd KO cells show a fourfold increase in hydrogenase activity and a 95% decrease in pyruvate/ferredoxin oxidoreductase (PFO) activity. In contrast, PFO and hydrogenase mRNA levels are unchanged. Surprisingly, Fd KO cells are not resistant to metronidazole under aerobic or anaerobic conditions. These cells are capable of producing molecular hydrogen, albeit at 50% the level of the parental strain, demonstrating that the Fd gene product eliminated in KO cells is neither necessary for hydrogen production nor metronidazole activation. Together these data indicate the presence of unidentified Fds or flavodoxins capable of drug activation or an unidentified mechanism that does not require either PFO or Fd for metronidazole activation.
PrintDisplayed: 1/10/2024 01:24